title: Prevalence of microalbuminuria in type 2 diabetes: lessons learned from the ROADMAP study.
authors.affiliation: Nierenzentrum, Im Neuenheimer Feld, Heidelberg D 69120, Germany. prof.e.ritz@t-online.de
authors.forename: Eberhard
authors.initials: E
authors.lastname: Ritz
authors.forename: Jan
authors.initials: J
authors.lastname: Menne
authors.forename: Hermann
authors.initials: H
authors.lastname: Haller
mesh_terms: D000419:Albuminuria / Q000453:epidemiology* / Q000209:etiology* / Q000517:prevention & control; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003928:Diabetic Nephropathies / Q000453:epidemiology* / Q000209:etiology*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D015995:Prevalence; D016032:Randomized Controlled Trials as Topic; D013777:Tetrazoles / Q000627:therapeutic use
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D007093:Imidazoles; D013777:Tetrazoles; C437965:olmesartan